On July 5, 1999 David Osborne Hagger appeared by Statement 476 before the BSE Inquiry.
On July 5, 1999 David Hagger appeared by Statement 476 before the inquiry into Bovine spongiform encephalopathy (mad cow disease BSE Inquiry), concerning the use of animal byproducts in use during the licensed manufacture of medicines in the United Kingdom.
Sources in France reported to the British Medicines Control Agency:"... that there were some licensed surgical sutures derived from French bovine material."  Concerns were also raised: "... regarding a possible risk of transmission of the BSE agent in gelatin products."
